Argitalpenak (10) JAVIER MOLEÓN MOYA argitalpenak

2023

  1. Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 12

  2. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 158

  3. Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation

    Pharmacological Research, Vol. 198

  4. Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study

    Gut Microbes, Vol. 15, Núm. 2

2022

  1. Trimethylamine n-oxide promotes autoimmunity and a loss of vascular function in toll-like receptor 7-driven lupus mice

    Antioxidants, Vol. 11, Núm. 1

2021

  1. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus

    British Journal of Pharmacology, Vol. 178, Núm. 18, pp. 3708-3729

  2. Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in toll-like receptor 7-driven lupus autoimmunity

    Antioxidants, Vol. 10, Núm. 9

  3. Probiotics prevent hypertension in a murine model of systemic lupus erythematosus induced by toll-like receptor 7 activation

    Nutrients, Vol. 13, Núm. 8

2020

  1. Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus

    Food & function, Vol. 11, Núm. 6, pp. 5266-5274

  2. Mycophenolate improves brain–gut axis inducing remodeling of gut microbiota in doca-salt hypertensive rats

    Antioxidants, Vol. 9, Núm. 12, pp. 1-18